Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2012. Start Trial.
Date Value
August 31, 2026 0.2262
May 31, 2026 0.2051
February 28, 2026 0.2527
November 30, 2025 0.1945
August 31, 2025 0.1609
May 31, 2025 0.1403
February 28, 2025 0.3854
November 30, 2024 0.2794
August 31, 2024 0.2102
May 31, 2024 0.1615
February 29, 2024 0.1333
November 30, 2023 0.1147
August 31, 2023 0.0937
May 31, 2023 0.00
February 28, 2023 0.00
November 30, 2022 0.00
August 31, 2022 0.00
May 31, 2022 0.00
February 28, 2022 0.00
November 30, 2021 0.00
August 31, 2021 0.00
May 31, 2021 0.00
February 28, 2021 0.00
November 30, 2020 0.00
August 31, 2020 0.00
Date Value
May 31, 2020 0.00
February 29, 2020 0.00
November 30, 2019 0.00
August 31, 2019 0.00
May 31, 2019 0.00
February 28, 2019 0.00
November 30, 2018 0.00
August 31, 2018 0.00
May 31, 2018 0.00
February 28, 2018 0.00
November 30, 2017 0.00
August 31, 2017 0.00
May 31, 2017 0.00
February 28, 2017 0.00
November 30, 2016 0.00
August 31, 2016 0.00
May 31, 2016 0.00
February 29, 2016 0.00
November 30, 2015 0.00
August 31, 2015 0.00
May 31, 2015 0.00
February 28, 2015 0.00
November 30, 2014 0.00
August 31, 2014 0.00
May 31, 2014 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Swedish Orphan Biovitrum AB 0.3557
Hansa Biopharma AB -1.987
BioArctic AB 0.0449
BONESUPPORT HOLDING AB 0.0107
BioInvent International AB 0.0677